Literature DB >> 15599641

Association of a single-nucleotide polymorphism in the immunoglobulin mu-binding protein 2 gene with immunoglobulin A nephropathy.

Shigeru Ohtsubo1,2, Aritoshi Iida3, Kosaku Nitta2, Toshihiro Tanaka4, Ryo Yamada5, Yozo Ohnishi4, Shiro Maeda6, Tatsuhiko Tsunoda7, Takashi Takei2, Wataru Obara8, Fumihiro Akiyama9, Kyoko Ito2, Kazuho Honda2, Keiko Uchida2, Ken Tsuchiya2, Wako Yumura2, Takashi Ujiie10, Yutaka Nagane11, Satoru Miyano1, Yasushi Suzuki8, Ichiei Narita9, Fumitake Gejyo9, Tomoaki Fujioka8, Hiroshi Nihei2, Yusuke Nakamura12.   

Abstract

Immunoglobulin A (IgA) nephropathy is the most common form of primary glomerulonephritis worldwide. The pathogenesis of IgA nephropathy is unknown, but it is certain that some genetic factors are involved in susceptibility to the disease. Employing a large-scale, case-control association study using gene-based single-nucleotide polymorphism (SNP) markers, we previously reported four candidate genes. We report here an additional significant association between IgA nephropathy and an SNP located in the gene encoding immunoglobulin micro-binding protein 2 (IGHMBP2) at chromosome 11q13.2-q13.4. The association (chi2 =17.1, p = 0.00003; odds ratio of 1.85 with 95% confidence interval of 1.39-2.50 in a dominant association model) was found using DNA from 465 affected individuals and 634 controls. The SNP (G34448A) caused an amino acid substitution from glutamine to lysine (E928K). As the gene product is involved in immunoglobulin-class switching and patients with the A allele revealed higher serum levels of IgA (p = 0.048), the amino acid change might influence a class switch to increase serum IgA levels, resulting in a higher risk of IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599641     DOI: 10.1007/s10038-004-0214-8

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  24 in total

1.  A high-throughput SNP typing system for genome-wide association studies.

Authors:  Y Ohnishi; T Tanaka; K Ozaki; R Yamada; H Suzuki; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

2.  Incidence of latent mesangial IgA deposition in renal allograft donors in Japan.

Authors:  Koichi Suzuki; Kazuho Honda; Kazunari Tanabe; Hiroshi Toma; Hiroshi Nihei; Yutaka Yamaguchi
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

3.  Association of the mammalian helicase MAH with the pre-mRNA splicing complex.

Authors:  G M Molnar; A Crozat; S K Kraeft; Q P Dou; L B Chen; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

4.  [Intercapillary deposits of IgA-IgG].

Authors:  J Berger; N Hinglais
Journal:  J Urol Nephrol (Paris)       Date:  1968-09

5.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.

Authors:  E Lander; L Kruglyak
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

Review 6.  Evidence for genetic factors in the development and progression of IgA nephropathy.

Authors:  S I Hsu; S B Ramirez; M P Winn; J V Bonventre; W F Owen
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

7.  IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23.

Authors:  A G Gharavi; Y Yan; F Scolari; F P Schena; G M Frasca; G M Ghiggeri; K Cooper; A Amoroso; B F Viola; G Battini; G Caridi; C Canova; A Farhi; V Subramanian; C Nelson-Williams; S Woodford; B A Julian; R J Wyatt; R P Lifton
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

8.  Smubp-2 represses the Epstein-Barr virus lytic switch promoter.

Authors:  Q Zhang; Y C Wang; E A Montalvo
Journal:  Virology       Date:  1999-03-01       Impact factor: 3.616

Review 9.  Inherited forms of IgA nephropathy.

Authors:  Francesco Scolari
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902

10.  Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus.

Authors:  M E Conley; M D Cooper; A F Michael
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

View more
  6 in total

1.  No association of monocyte chemoattractant protein-1 -2518 A/G polymorphism with the risk of primary glomerulonephritis in the Polish population.

Authors:  Magdalena Mostowska; Margarita Lianeri; Andrzej Oko; Adrianna Mostowska; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

2.  Genetic contribution and associated pathophysiology in end-stage renal disease.

Authors:  Suraksha Agrawal; Ss Agarwal; Sita Naik
Journal:  Appl Clin Genet       Date:  2010-08-05

3.  Development of a model of early-onset IgA nephropathy.

Authors:  Keiko Okazaki; Yusuke Suzuki; Mareki Otsuji; Hitoshi Suzuki; Masao Kihara; Tadahiro Kajiyama; Azusa Hashimoto; Hiroyuki Nishimura; Rhubell Brown; Stacy Hall; Jan Novak; Shozo Izui; Sachiko Hirose; Yasuhiko Tomino
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

Review 4.  Treatment strategy with multidrug therapy and tonsillectomy pulse therapy for childhood-onset severe IgA nephropathy.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2022-02-04       Impact factor: 2.801

Review 5.  Genetic studies of IgA nephropathy: past, present, and future.

Authors:  Krzysztof Kiryluk; Bruce A Julian; Robert J Wyatt; Francesco Scolari; Hong Zhang; Jan Novak; Ali G Gharavi
Journal:  Pediatr Nephrol       Date:  2010-04-13       Impact factor: 3.714

Review 6.  Genetics and immunopathogenesis of IgA nephropathy.

Authors:  Hsin-Hui Yu; Kuan-Hua Chu; Yao-Hsu Yang; Jyh-Hong Lee; Li-Chieh Wang; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.